Investing Profile

Paul Eisenberg

InvestorVC
Chief Medical Officer & Venture Partner at ATP
Photo of Paul Eisenberg, Venture Partner at ATP (Apple Tree Partners)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
1
CompanyStageDateRound SizeTotal Raised
Deep Apple Therapeutics
Series ADec 2023$52M
$52M
Co-investors: Michael Ehlers (ATP (Apple Tree Partners)), Paul Da Silva Jardine (ATP (Apple Tree Partners)), Seth L. Harrison (ATP (Apple Tree Partners)), Spiros Liras (ATP (Apple Tree Partners))
Venture Partner Apple Tree Partners2019 - Present
SVP Global Medical Amgen2017 - 2019
SVP Global Medical and CMO Amgen2014 - 2017
SVP-Regulatory and Safety Amgen2008 - 2014
VP- Global Regulatory and Safety Amgen2006 - 2008
VP of Safety Amgen2005 - 2006
VP of Global Patient Safety Eli Lilly and Company2002 - 2005
VP of General Medicine Eli Lilly and Company2000 - 2002
ED Cardiovascular Therapeutic Area and Discovery Eli Lilly and Company1998 - 2000
Professor of Medicine Washington University in St. Louis1983 - 1998
New York Medical College Doctor of Medicine (M.D.)
Tulane University School of Public Health and Tropical Medicine MPH&TM Tropical Medicine